What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity February 22, 2021
- Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus February 22, 2021
- Genetic association of a gain of function interferon gamma receptor 1 (IFNGR1) polymorphism and the intergenic region LNCAROD/DKK1 with Behçet's disease January 4, 2021
- Ovarian antibodies among SLE women with premature menopause after cyclophosphamide December 10, 2020
- Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus November 20, 2020
- TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNα production September 26, 2020
- ARID3a expression in human hematopoietic stem cells is associated with distinct gene patterns in aged individuals September 9, 2020